News and Announcements
What Investors Look For In Each Startup Stage
- Published December 20, 2022 3:22AM UTC
- Publisher Leila Oliveira
- Categories Capital Raising Tips
What investors are looking for in each stage of your startup:
– Pre-seed
You are selling a vision of what it could be instead of what you’ve already done.
Focus on: Team experience, your secret sauce, a great pitch deck and market opportunity.
– Seed
What evidence do you already have that this will be successful?
Focus on: Pre-seed metrics + EOI/active users/early traction/followers and engagement on social media. Anything that can showcase the demand for the product.
– Series A
How much can you scale this business in the next 12-15 months?
Focus on: Seed metrics + existing investors, strong board management, growth metrics
-Series B and Beyond
Investors are looking for liquidity. When and how is it happening?
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
